Izotropic Corporation (IZO.CN)

CAD 0.04

(-20.0%)

Market Cap (In CAD)

2.27 Million

Revenue (In CAD)

-

Net Income (In CAD)

-1.56 Million

Avg. Volume

12.34 Thousand

Currency
CAD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.035-0.22
PE
-
EPS
-
Beta Value
1.867
ISIN
CA46604F1099
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Robert Louis Thast
Employee Count
-
Website
https://izocorp.com
Ipo Date
2018-06-06
Details
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.